The role of bcl-2 in spontaneous and drug-induced apoptosis in multiple myeloma (MM) is not yet established, particularly since the frequency of t(14:18) in MM is relatively low. In recent studies, we have investigated the steady-state levels of bcl-2 mRNA transcripts and bcl-2 protein in 8 MM cell lines and found inverse correlation between the levels of bcl-2 and sensitivity to dexamethasone (DEX)-induced apoptosis. Moreover, we have shown that bcl-2 was further down-regulated in DEX sensitive cell lines, but not in DEX resistance cell lines, in the course of DEX-induced apoptosis (Int J Oncol 8: 719-726, 1996). Herein, we report the results of transfection studies of 2 DEX sensitive MM cell lines, expressing relatively low levels of bcl-2, with a bcl-2 inducible gene construct expressed under the control of lac repressor operon. Thus, switching-on of bcl-2 by IPTG resulted in increased bcl-2 protein in the cells, enhancement of cell growth, and a decrease in spontaneous apoptosis, concomitant with increased resistance to DEX. Switching-off of bcl-2 protein expression by removal of IPTG resulted in restoration of sensitivity to DEX-induced apoptosis. We, therefore, conclude that bcl-2 plays a central role in cell growth and in spontaneous and induced apoptosis in MM cell lines.
No takes yet. Share an insight, caveat, or question.
Tian et al. (1996) studied this question.